<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Understanding and Predicting Outcomes in CAR T-cell Therapy for Aggressive Lymphoma

Steven Bair, MD

minute read

Watch the Department of Medicine's Research and Innovation Conference, April 7, 2022: "Understanding and predicting outcomes in CAR T-cell therapy for aggressive lymphoma" | Steven Bair, MD, assistant professor, Division of Hematology, University of Colorado | Anschutz Medical Campus.


Topics: Research